Download Files:
Ebaresdax
SKU
HY-139569-10 mg
Category Reference compound
Tags Endogenous Metabolite, Metabolic Enzyme/Protease, Neurological Disease
$300 – $2,250
Products Details
Product Description
– Ebaresdax (ACP-044) can inhibit peroxynitrite oxidation derived by SIN-1 and peroxynitrite mediated Cytotoxicity with IC50s of 3.7±0.80 and 0.13±0.02 uM, respectively[1].
Web ID
– HY-139569
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C12H14N2O3S
References
– [1]Mannion, James C.; Dax, Scott L. Analgesic compounds, compositions, and uses thereof. WO2011112602A1
CAS Number
– 1334471-39-4
Molecular Weight
– 266.32
Compound Purity
– 99.89
SMILES
– OC([C@H](C(C)(S1)C)N=C1NC2=C(C=CC=C2)O)=O
Clinical Information
– Phase 2
Research Area
– Neurological Disease
Solubility
– DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Endogenous Metabolite
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.